{
    "nctId": "NCT00356148",
    "briefTitle": "The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.",
    "officialTitle": "Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 372,
    "primaryOutcomeMeasure": "Number of Patients With Body Mass Index (BMI) Over 25 Who Developed Surgical Site Infection (SSI) in Groups Who Received Antibiotic Prophylaxis (Prophylaxis Group) and no Prophylaxis (No Prophylaxis Group).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II.\n\nExclusion Criteria:\n\n* Ductal carcinoma in situ (DCIS; stage 0 cancer),\n* Advanced or distant metastatic stage,\n* Receiving any neoadjuvant therapy,\n* History of receiving any antibiotics within prior 3 months,\n* History of immunodeficiency,\n* Having a remote infection,\n* History of reaction to study antibiotics,\n* Denial of signing the consent form.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}